INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,764,976 | -48.9% | 109,504 | -57.3% | 0.00% | -40.0% |
| Q2 2023 | $5,406,031 | +113.1% | 256,210 | +72.2% | 0.01% | +150.0% |
| Q1 2023 | $2,537,176 | -7.7% | 148,808 | +8.2% | 0.00% | -33.3% |
| Q4 2022 | $2,748,509 | +46.0% | 137,563 | +57.5% | 0.00% | +50.0% |
| Q3 2022 | $1,882,000 | +8.9% | 87,359 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $1,728,000 | +43.3% | 87,647 | +70.9% | 0.00% | +100.0% |
| Q1 2022 | $1,206,000 | -3.6% | 51,300 | +11.1% | 0.00% | 0.0% |
| Q4 2021 | $1,251,000 | -1.1% | 46,187 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $1,265,000 | -63.2% | 46,157 | -61.9% | 0.00% | -66.7% |
| Q2 2021 | $3,442,000 | +309.8% | 121,157 | +252.2% | 0.00% | +200.0% |
| Q2 2015 | $840,000 | +55.3% | 34,400 | +32.3% | 0.00% | 0.0% |
| Q1 2015 | $541,000 | -60.1% | 26,000 | -70.1% | 0.00% | 0.0% |
| Q3 2013 | $1,357,000 | – | 86,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |